BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 23349193)

  • 1. Nonuremic indication for peritoneal dialysis for refractory heart failure in cardiorenal syndrome type II: review and perspective.
    Nakayama M
    Perit Dial Int; 2013; 33(1):8-14. PubMed ID: 23349193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal dialysis in patients with heart failure.
    Van Der Sande FM; Cnossen TT; Cornelis T; Konings CJ; Kooman JP; Leunissen KM
    Minerva Urol Nefrol; 2012 Sep; 64(3):163-72. PubMed ID: 22971681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal Dialysis for Chronic Congestive Heart Failure.
    François K; Ronco C; Bargman JM
    Blood Purif; 2015; 40(1):45-52. PubMed ID: 26111872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tidal peritoneal dialysis versus ultrafiltration in type 1 cardiorenal syndrome: A prospective randomized study.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Audah N; Al-Hwiesh A; Al-Harbi M; Taha A; Al-Shahri A; Ghazal S; Amir R; Al-Audah N; Mansour H; El-Mansouri M; El-Salamony TS; Nasr El-Din MA; Noor A; Al-Elq Z; Alzahir ZH; Alzawad NA
    Int J Artif Organs; 2019 Dec; 42(12):684-694. PubMed ID: 31303099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and Safety of Peritoneal Dialysis Treatment in Patients with Refractory Congestive Heart Failure due to Chronic Cardiorenal Syndrome.
    Shao Q; Xia Y; Zhao M; Liu J; Zhang Q; Jin B; Xie J; Xu B; Gong R; Jiang C
    Biomed Res Int; 2018; 2018():6529283. PubMed ID: 29888270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volume control in treatment-resistant congestive heart failure: role for peritoneal dialysis.
    Broekman KE; Sinkeler SJ; Waanders F; Bartels GL; Navis G; Janssen WM
    Heart Fail Rev; 2014 Nov; 19(6):709-16. PubMed ID: 24442648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parameters associated with therapeutic response using peritoneal dialysis for therapy refractory heart failure and congestive right ventricular dysfunction.
    Pavo N; Yarragudi R; Puttinger H; Arfsten H; Strunk G; Bojic A; Hülsmann M; Vychytil A
    PLoS One; 2018; 13(11):e0206830. PubMed ID: 30452453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The peritoneal ultrafiltration in patients with cardio-renal disease].
    Corciulo R; Corciulo S
    G Ital Nefrol; 2017 Mar; 34(Suppl 69):86-103. PubMed ID: 28682031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Cardiorenal Syndrome.
    Rubinstein J; Sanford D
    Cardiol Clin; 2019 Aug; 37(3):267-273. PubMed ID: 31279420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiorenal syndrome, current understanding].
    Ronco F; Ronco C
    Recenti Prog Med; 2009 Apr; 100(4):202-13. PubMed ID: 19554920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Customization of Peritoneal Dialysis in Cardiorenal Syndrome by Optimization of Sodium Extraction.
    Kazory A; Koratala A; Ronco C
    Cardiorenal Med; 2019; 9(2):117-124. PubMed ID: 30726844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of peritoneal dialysis as a chronic renal replacement therapy in cardiorenal patients.
    Pego C; Rodrigues A; Ronco C
    Contrib Nephrol; 2012; 178():182-188. PubMed ID: 22652735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure.
    Ronco C; Cicoira M; McCullough PA
    J Am Coll Cardiol; 2012 Sep; 60(12):1031-42. PubMed ID: 22840531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
    Mehta RL; Rabb H; Shaw AD; Singbartl K; Ronco C; McCullough PA; Kellum JA
    Contrib Nephrol; 2013; 182():174-94. PubMed ID: 23689662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of cardiorenal syndrome in patients with heart failure: potential therapeutic targets.
    Takahama H; Kitakaze M
    Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H715-H721. PubMed ID: 28733448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Cardiorenal Syndrome].
    Scurt FG; Kuczera T; Mertens PR; Chatzikyrkou C
    Dtsch Med Wochenschr; 2019 Jul; 144(13):910-916. PubMed ID: 31252445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart-Kidney Interactions in Cardiorenal Syndrome Type 1.
    Palazzuoli A; Ruocco G
    Adv Chronic Kidney Dis; 2018 Sep; 25(5):408-417. PubMed ID: 30309458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal contributions to cardiorenal dysfunction in congestive heart failure.
    Verbrugge FH; Dupont M; Steels P; Grieten L; Malbrain M; Tang WH; Mullens W
    J Am Coll Cardiol; 2013 Aug; 62(6):485-95. PubMed ID: 23747781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal replacement therapy in congestive heart failure requiring left ventricular assist device augmentation.
    Thomas BA; Logar CM; Anderson AE
    Perit Dial Int; 2012; 32(4):386-92. PubMed ID: 22859837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visions in a Crystal Ball: The Future of Peritoneal Dialysis.
    Bargman JM; Girsberger M
    Blood Purif; 2018; 45(1-3):218-223. PubMed ID: 29478058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.